Abstract

It was a pleasant surprise for those of us in the Outcomes Research community to see a health economist lead the Food and Drug Administration (FDA) albeit for a very short time. In this issue, Value in Health presents its transcript of a speech Dr Mark McClellan gave at ISPOR last year.